American Biomanufacturing Summit

Lunch & Learn

Roundtables

12:50 pm – 1:50 pm

Day 1

Table 1

[full_table_info form_id="29" table="1" day="1" year="2025"]

TABLE 2

[full_table_info form_id="29" table="2" day="1" year="2025"]

TABLE 3

[full_table_info form_id="29" table="3" day="1" year="2025"]

TABLE 4

[full_table_info form_id="29" table="4" day="1" year="2025"]

TABLE 5

[full_table_info form_id="29" table="5" day="1" year="2025"]

TABLE 6

[full_table_info form_id="29" table="6" day="1" year="2025"]

TABLE 7

[full_table_info form_id="29" table="7" day="1" year="2025"]

TABLE 8

[full_table_info form_id="29" table="8" day="1" year="2025"]

TABLE 9

[full_table_info form_id="29" table="9" day="1" year="2025"]

TABLE 10

[full_table_info form_id="29" table="10" day="1" year="2025"]

TABLE 11

[full_table_info form_id="29" table="11" day="1" year="2025"]

Day 2

Table 1

Rahul Kaushik

Chief Technical Officer
Disc Medicine

What, how, when: navigating CMC considerations for programs on an accelerated approval pathway

Spots Remaining: 0

TABLE 2

Andy Lin

VP and Global Head, Individualized and Cell Therapy Development, Pharma Technical
Genentech

Enhancing the Development and Manufacturing of Individualized Cell Therapies

Spots Remaining: 0

TABLE 3

Andrew Wirths

SVP, Global Operations
AstraZeneca

Achieving Carbon Zero: AstraZeneca's Path to Sustainability in Manufacturing

Spots Remaining: 0

TABLE 4

Christopher Grail

SVP and Head, Global Pharma Engineering
Bayer

Danielle Golay

VP, Biologics and Cell Therapy Quality
Bayer

Synergistic Collaboration Between Production, Engineering and Quality as Important Success Factors In Manufacturing

Spots Remaining: 0

TABLE 5

Suki Toguchi

Chief of Staff
Gilead Sciences

Leading Digital Strategy: Driving Transformation Across Gilead’s Pharma Development and Manufacturing

Spots Remaining: 0

TABLE 6

Rakesh Kakkar

VP and Head, Manufacturing and Supply Vaccines, US
Sanofi

Driving Operational excellence, Quality and Compliance in Biomanufacturing

Spots Remaining: 0

TABLE 7

Keñya Edmondson

VP, Sterile Injectables Operations
Pfizer

Talent Development in Biopharma: Cultivating the Next Generation

Spots Remaining: 0

TABLE 8

Nooshafarin Sanaie

VP, Process and Analytical Development
Poseida Therapeutics

Scaling Allogeneic CAR-T Manufacturing: Overcoming Challenges and Driving Innovation

Spots Remaining: 1

TABLE 9

Kara Renai King

Platform Leader, Americas and China and Lead, Global Manufacturing Learning and Development
Zoetis

MEET THE SPEAKER

Spots Remaining: 0

TABLE 10

RJ Doornbos

VP, Quality Operating Systems and Services
Amgen

MEET THE SPEAKER

Spots Remaining: 0

TABLE 11

Ben Beneski

SVP and Chief Technical Officer
Allogene Therapeutics

MEET THE SPEAKER

Spots Remaining: 0